T1	Eq-Comparison 34 53	older than 18 years
E1	Eq-Comparison:T1 Operator:T42 Value:T43 Temporal-Unit:T44
T2	Condition 85 105	rheumatoid arthritis
E2	Condition:T2 Name:T45
T3	Condition 119 122	ACR
E3	Condition:T3
T4	Or 123 124	/
E4	Or:T4
T5	Eq-Comparison 166 182	moderate to high
E5	Eq-Comparison:T5 Operator:T47
T6	Observation 183 199	disease activity
E6	Observation:T6 Name:T49
T7	Observation 201 204	DAS
E7	Observation:T7 Name:T50
T8	Eq-Comparison 212 234	score greater than 3.2
E8	Eq-Comparison:T8 Operator:T51 Value:T52
T9	Eq-Comparison 250 258	received
E9	Eq-Comparison:T9 Temporal-Period:T53
T10	Procedure 263 279	standard therapy
E10	Procedure:T10 Name:T54
T11	Eq-Comparison 286 297	one or more
E11	Eq-Comparison:T11 Value:T55 Operator:T56
T12	Procedure 298 317	conventional DMARDs
E12	Procedure:T12
T13	Eq-Comparison 323 344	at least three months
E13	Eq-Comparison:T13 Operator:T58 Value:T59 Temporal-Unit:T60
T14	Condition 377 393	hypersensitivity
E14	Condition:T14 Name:T61
T15	Drug 397 406	metformin
E15	Drug:T15 Name:T62
T16	Eq-Comparison 433 438	prior
E16	Eq-Comparison:T16 Temporal-Period:T63
T17	Condition 454 471	diabetes mellitus
E17	Condition:T17 Name:T64
T18	Eq-Comparison 487 494	receive
E18	Eq-Comparison:T18 Temporal-Period:T65
T19	Drug 495 504	metformin
E19	Drug:T19 Name:T66
T20	Other 513 518	other
E20	Other:T20
T21	Condition 551 575	congestive heart failure
E21	Condition:T21 Name:T67
T22	Eq-Comparison 598 605	history
E22	Eq-Comparison:T22 Temporal-Period:T68
T23	Condition 609 630	myocardial infarction
E23	Condition:T23 Name:T69
T24	Condition 658 664	anemia
E24	Condition:T24 Name:T71
T25	Eq-Comparison 685 691	active
E25	Eq-Comparison:T25 Temporal-Period:T72
T26	Condition 692 702	infections
E26	Condition:T26 Name:T73
T27	Or 703 705	or
E27	Or:T27
T28	Other 706 711	other
E28	Other:T28
T29	Condition 712 733	inflammatory diseases
E29	Condition:T29 Name:T74
T30	Eq-Comparison 749 758	receiving
E30	Eq-Comparison:T30 Temporal-Period:T75
T31	Procedure 759 777	biological therapy
E31	Procedure:T31 Name:T76
T32	Condition 784 793	Pregnancy
E32	Condition:T32 Name:T77
T33	Or 794 796	or
E33	Or:T33
T34	Condition 797 806	lactation
E34	Condition:T34 Name:T78
T35	Condition 827 851	impaired liver functions
E35	Condition:T35 Name:T79
T36	Condition 872 897	impaired kidney functions
E36	Condition:T36 Name:T80
T37	Observation 899 930	serum creatinine concentrations
E37	Observation:T37 Name:T81
T38	Eq-Comparison 931 950	≥1.5 and ≥1.4 mg/dL
E38	Eq-Comparison:T38 Operator:T82 Value:T83 Unit:T84 Unit:T85
T39	Or 960 963	and
E39	Or:T39
T40	Eq-Comparison 972 984	respectively
E40	Eq-Comparison:T40
T41	Condition 1006 1018	malignancies
E41	Condition:T41 Name:T88
T42	Eq-Operator 34 44	older than
A1	Eq-Operator-Value T42 GT
T43	Eq-Value 45 47	18
T44	Eq-Temporal-Unit 48 53	years
A2	Eq-Temporal-Unit-Value T44 year
T45	Condition-Name 85 105	rheumatoid arthritis
T46	Severity 166 174	moderate
A3	Severity-Value T46 moderate
T47	Eq-Operator 175 177	to
A4	Eq-Operator-Value T47 BETWEEN
T48	Polarity 178 182	high
A5	Polarity-Value T48 high
T49	Observation-Name 183 199	disease activity
A6	Observation-Type-Value T49 social-habit
T50	Observation-Name 201 204	DAS
T51	Eq-Operator 218 230	greater than
A7	Eq-Operator-Value T51 GT
T52	Eq-Value 231 234	3.2
T53	Eq-Temporal-Period 250 258	received
A8	Eq-Temporal-Period-Value T53 past
T54	Procedure-Name 263 279	standard therapy
T55	Eq-Value 286 289	one
T56	Eq-Operator 290 297	or more
A9	Eq-Operator-Value T56 GTEQ
T57	Drug-Name 311 317	DMARDs
T58	Eq-Operator 323 331	at least
A10	Eq-Operator-Value T58 GTEQ
T59	Eq-Value 332 337	three
T60	Eq-Temporal-Unit 338 344	months
A11	Eq-Temporal-Unit-Value T60 month
T61	Condition-Name 377 393	hypersensitivity
T62	Drug-Name 397 406	metformin
T63	Eq-Temporal-Period 433 438	prior
A12	Eq-Temporal-Period-Value T63 past
T64	Condition-Name 454 471	diabetes mellitus
T65	Eq-Temporal-Period 487 494	receive
A13	Eq-Temporal-Period-Value T65 present
T66	Drug-Name 495 504	metformin
T67	Condition-Name 551 575	congestive heart failure
T68	Eq-Temporal-Period 598 605	history
A14	Eq-Temporal-Period-Value T68 past
T69	Condition-Name 609 630	myocardial infarction
T70	Severity 651 657	severe
A15	Severity-Value T70 severe
T71	Condition-Name 658 664	anemia
T72	Eq-Temporal-Period 685 691	active
A16	Eq-Temporal-Period-Value T72 present
T73	Condition-Name 692 702	infections
T74	Condition-Name 712 733	inflammatory diseases
T75	Eq-Temporal-Period 749 758	receiving
A17	Eq-Temporal-Period-Value T75 present
T76	Procedure-Name 759 777	biological therapy
T77	Condition-Name 784 793	Pregnancy
T78	Condition-Name 797 806	lactation
T79	Condition-Name 827 851	impaired liver functions
T80	Condition-Name 872 897	impaired kidney functions
T81	Observation-Name 899 930	serum creatinine concentrations
A18	Observation-Type-Value T81 lab
T82	Eq-Operator 931 935	≥1.5
A19	Eq-Operator-Value T82 GTEQ
T83	Eq-Value 940 944	≥1.4
T84	Eq-Unit 945 947	mg
T85	Eq-Unit 948 950	dL
T86	Life-Stage-And-Gender 954 959	males
A20	Life-Stage-And-Gender-Type T86 male
T87	Life-Stage-And-Gender 964 971	females
A21	Life-Stage-And-Gender-Type T87 female
T88	Condition-Name 1006 1018	malignancies